William R. Miller VIEW CLINICAL PROFILE

William R. Miller, MD

Assistant Professor of Medicine, Academic Institute
Assistant Clinical Member, Research Institute
Houston Methodist


VIEW CLINICAL PROFILE
Publications

Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin.
Egge, SL, Rizvi, SA, Simar, SR, Alcalde, M, Martinez, JRW, Hanson, BM, Dinh, AQ, Baptista, RP, Tran, TT, Shelburne, SA, Munita, JM, Arias, CA, Hakki, M & Miller, WR 2024, , Antimicrobial Agents and Chemotherapy, pp. e0012724. https://doi.org/10.1101/2024.01.30.578008, https://doi.org/10.1128/aac.00127-24

Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin.
Egge, SL, Rizvi, SA, Simar, SR, Alcalde, M, Martinez, JRW, Hanson, BM, Dinh, AQ, Baptista, RP, Tran, TT, Shelburne, SA, Munita, JM, Arias, CA, Hakki, M & Miller, WR 2024, , Antimicrobial Agents and Chemotherapy, pp. e0012724. https://doi.org/10.1128/aac.00127-24

Prevalence of the Cefazolin Inoculum Effect (CzIE) in Nasal Colonizing Methicillin-Susceptible Staphylococcus aureus in Patients from Intensive Care Units in Colombia and Use of a Modified Rapid Nitrocefin Test for Detection.
Carvajal, LP, Rincon, S, Gomez-Villegas, SI, Matiz-González, JM, Ordoñez, K, Santamaria, A, Ospina-Navarro, L, Beltran, J, Guevara, F, Mendez, YR, Salcedo, S, Porras, A, Valencia-Moreno, A, Grennia, H, Deyanov, A, Baptista, R, Tam, VH, Panesso, D, Tran, TT, Miller, WR, Arias, CA & Reyes, J 2024, , medRxiv. https://doi.org/10.1101/2024.07.11.24309236

Comparison of cefiderocol in-vitro susceptibility testing modalities
Teran, NS, Vuong, L, Phe, K, Lasco, TM, Miller, WR & Tam, VH 2024, , Journal of Global Antimicrobial Resistance, vol. 37, pp. 100-101. https://doi.org/10.1016/j.jgar.2024.03.011

Clinical Features and Genomic Epidemiology of Bloodstream Infections due to Enterococcal Species Other Than Enterococcus faecalis or E. faecium in Patients With Cancer
Axell-House, DB, Ashley, PA, Egge, SL, Tran, TT, Pedroza, C, Zhang, M, Dinh, AQ, Simar, SR, Sahasrabhojane, PV, Miller, WR, Shelburne, SA, Hanson, BM & Arias, CA 2024, , Open Forum Infectious Diseases, vol. 11, no. 6. https://doi.org/10.1093/ofid/ofae288

Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates
Westbrook, KJ, Chilambi, GS, Stellfox, ME, Nordstrom, HR, Li, Y, Iovleva, A, Shah, NH, Jones, CE, Kline, EG, Squires, KM, Miller, WR, Tran, TT, Arias, CA, Doi, Y, Shields, RK & Tyne, DV 2024, , Journal of Antimicrobial Chemotherapy, vol. 79, no. 4, pp. 801-809. https://doi.org/10.1093/jac/dkae032

LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium
Axell-House, DB, Simar, SR, Panesso, D, Rincon, S, Miller, WR, Khan, A, Pemberton, OA, Valdez, L, Nguyen, AH, Hood, KS, Rydell, K, DeTranaltes, AM, Jones, MN, Atterstrom, R, Reyes, J, Sahasrabhojane, PV, Suleyman, G, Zervos, M, Shelburne, S, Singh, KV, Shamoo, Y, Hanson, BM, Tran, TT & Arias, CA 2024, , Antimicrobial Agents and Chemotherapy, vol. 68, no. 3. https://doi.org/10.1128/aac.01069-23

LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium
Axell-House, DB, Simar, SR, Panesso, D, Rincon, S, Miller, WR, Khan, A, Pemberton, OA, Valdez, L, Nguyen, AH, Hood, KS, Rydell, K, DeTranaltes, AM, Jones, MN, Atterstrom, R, Reyes, J, Sahasrabhojane, PV, Suleyman, G, Zervos, M, Shelburne, S, Singh, KV, Shamoo, Y, Hanson, BM, Tran, TT & Arias, CA 2024, , Antimicrobial Agents and Chemotherapy, vol. 68, no. 3. https://doi.org/10.1128/aac.01069-23

The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy
Teran, N, Egge, SL, Phe, K, Baptista, RP, Tam, VH & Miller, WR 2024, , Antimicrobial Agents and Chemotherapy, vol. 68, no. 1. https://doi.org/10.1128/aac.01009-23

The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy.
Teran, N, Egge, SL, Phe, K, Baptista, RP, Tam, VH & Miller, WR 2024, , Antimicrobial Agents and Chemotherapy, vol. 68, no. 1, pp. e0100923. https://doi.org/10.1128/aac.01009-23

Membrane Lipids Augment Cell Envelope Stress Signaling and Resistance to Antibiotics and Antimicrobial Peptides in Enterococcus faecalis
Miller, WR, Nguyen, A, Singh, KV, Rizvi, S, Khan, A, Erickson, SG, Egge, S, Cruz, MR, Dinh, A, Diaz, L, Zhang, R, Xu, L, Garsin, DA, Shamoo, Y & Arias, CA 2023, , bioRxiv, pp. 1 - 30. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614854/>

High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated ß-lactamase CMY-185 variant
Shropshire, WC, Endres, BT, Borjan, J, Aitken, SL, Bachman, WC, Mcelheny, CL, Wu, CT, Egge, SL, Khan, A, Miller, WR, Bhatti, MM, Saharasbhojane, P, Kawai, A, Shields, RK, Shelburne, SA & Doi, Y 2023, , Journal of Antimicrobial Chemotherapy, vol. 78, no. 10, pp. 2442-2450. https://doi.org/10.1093/jac/dkad249

The response of mpox-associated inflammatory syndrome to steroid therapy
Arias, CA, Miller, WR, Olsen, RJ, Gollihar, J & Armstrong, A 2023, , The Lancet Infectious Diseases, vol. 23, no. 8, pp. e323-e324. https://doi.org/10.1016/S1473-3099(22)00876-3

Evolving landscape of carbapenem-resistant Pseudomonas aeruginosa at a single centre in the USA
Sakurai, A, Dinh, AQ, Hanson, BM, Shropshire, WC, Rizvi, SA, Rydell, K, Tran, TT, Wanger, A, Arias, CA & Miller, WR 2023, , JAC-Antimicrobial Resistance, vol. 5, no. 3, dlad070, pp. dlad070. https://doi.org/10.1093/jacamr/dlad070

Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA
Tran, TT, Cabrera, NL, Gonzales-Luna, AJ, Carlson, TJ, Alnezary, F, Miller, WR, Sakurai, A, Dinh, AQ, Rydell, K, Rios, R, Diaz, L, Hanson, BM, Munita, JM, Pedroza, C, Shelburne, SA, Aitken, SL, Garey, KW, Dillon, R, Puzniak, L & Arias, CA 2023, , JAC-Antimicrobial Resistance, vol. 5, no. 1, dlac131, pp. dlac131. https://doi.org/10.1093/jacamr/dlac131

Evaluation of Cefazolin High Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus (MSSA) Using Gold standard MICs and Rapid Colorimetric Test (RCT)
Malikazad, H, Rizvi, S, Venugopalan, V, Santevechi, B, Panesso, D, Singh, KV, Gomez, S, Tran, C, Jacques-Palaz, KD, Miller, WR & Arias, CA 2023, , 6th Annual Texas Medical Center Antimicrobial Resistance and Stewardship Conference, January 18-20, 2023, Houston, United States, 1/18/23 - 1/20/23.

A Case of successful treatment of recurrent urinary tract infection by extended-spectrum ß-lactamase producing klebsiella pneumoniae using oral lyophilized fecal microbiota transplant
Bier, N, Hanson, B, Jiang, ZD, Dupont, HL, Arias, CA & Miller, WR 2023, , Microbial Drug Resistance, vol. 29, no. 1, pp. 34-38. https://doi.org/10.1089/mdr.2022.0031

Optimization of a Nitrocefin-Based Rapid Test for the Detection of the Cefazolin Inoculum Effect (CzIE) in MSSA
Villegas, SG, Panesso, D, Singh, KV, Rincon, S, Carvajal, LP, Jacques-Palaz, KD, Rizvi, S, Reyes, MI, Abbott, A, Burnham, CAD, Bard, JD, Westblade, LF, Fritz, S, Zimmer, B, Dingle, TC, Butler-Wu, S, Miller, WR, Reyes, J & Arias, CA 2023, , IDWeek 2023 , Boston, United States, 10/11/23 - 10/15/23.

LiaX is a surrogate marker for cell-envelope stress and daptomycin non-susceptibility in Enterococcus faecium
Axell-House, DB, Simmar, S, Rincon, S, Miller, WR, Khan, A, Pemberton, O, Valdez, L, Nguyen, A, Hood, KS, Rydell, K, DeTranaltes, AM, Jones, MN, Atterstrom, R, Reyes, J, Sahasrabhojane, P, Suleyman, G, Zervos, MJ, Shelburne, SA, Singh, KV, Shamoo, Y, Hanson, BM, Tran, C & Arias, CA 2023, , bioRxiv.

The enterococci
Nguyen, AH, Axell-House, DB, Miller, WR & Arias, CA 2023, . in Molecular Medical Microbiology, Third Edition. Elsevier, pp. 755-774. https://doi.org/10.1016/B978-0-12-818619-0.00046-0

VIEW FULL PUBLICATIONS